Acutus Medical
Acutus Medical pulls in $26M
Acutus Medical said it secured $26.2 million in new funding for the cardiac mapping technology it’s developing to image and map atrial fibrillation hotspots.
Acutus lands European approval for heart-mapping ‘Katheter’
European regulators approved Acutus Medical’s flagship ‘Katheter’ device, a diagnostic catheter for real-time 3D imaging and mapping of the heart.
The Katheter is just a part of Acutus Medical’s larger stand-alone system, the company said. The device contains 48 ultrasound crystals and electrodes that capture both the geometry of the heart and its electrical activity.
Acutus closes Series B round at $28M, with funding from GE and OrbiMed
San Diego medical device startup Acutus Medical closed its Series B funding round with $28 million raised from a handful of investors in support of the company’s minimally invasive heart mapping technology.
Acutus Medical charts $21M of a hoped-for $31M Series B round
Acutus Medical, fresh off a successful first-in-human trial of its heart-mapping technology, raised $21.6 million of a hoped-for $30.6 million Series B round, founder, president & CEO Randy Werneth told MassDevice.com today.
Edwards lands four-year $500 million revolving credit facility | Funding Roundup
Edwards Lifesciences Corp. (NYSE:EW) landed a new four-year $500 million credit facility after canceling a prior one a couple months early.
The old facility was a five-year deal, also for $500 million, that was scheduled to mature September 29, 2011.